Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia

NEXT STORY
Kiniksa Announces Positive Data from Phase 3 Trial of Rilonacept in Recurrent Pericarditis (RHAPSODY)
PREV STORY
Tonix Pharmaceuticals Announces Enrollment of Phase 3 RELIEF Trial of TNX-102 SL for Management of Fibromyalgia is Ahead of Schedule
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunovaccine to Present at 2018 BIO CEO & Investor Conference

HALIFAX, Nova Scotia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

author_avatar
NASDAQ Market News

Health Needs Spike for Survivors of Indonesia’s Earthquake and Tsunami

Millwood, VA, Oct. 06, 2018 (GLOBE NEWSWIRE) -- Project HOPE says serious health needs ...

author_avatar
NASDAQ Market News

NANOBIOTIX’ Management statement on recent share price variation

        NANOBIOTIX' MANAGEMENT STATEMENT ON RECENT SHARE PRICE VARIATION Paris, France and ...

author_avatar
NASDAQ Market News